Safety and Efficacy of a 2,910 nm Fractional Ablative Fiber Laser (UltraClear®) for Improvements of Skin Laxity and Lifting of the Lower Face, Submental, and Neck Treatment Areas | MicrobiomeTrials
Safety and Efficacy of a 2,910 nm Fractional Ablative Fiber Laser (UltraClear®) for Improvements of Skin Laxity and Lifting of the Lower Face, Submental, and Neck Treatment Areas
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-08-07Est. Completion: 2027-08-31
Enrollment target: 50 participants
Locations
Julene B Samuels MD, FACS, Prospect, Kentucky, United States
Dermatology & Laser Surgery Center, Houston, Texas, United States